Heikinmäki, N., tiedekunta, M., Sciences, F. o., laitos, B. j. y., Science, D. o. B. a. E., yliopisto, J., & Jyväskylä, U. o. (2022). Validation of the breast cancer Analysis Protocol Packages (APPs) for the determination of estrogen and progesterone receptors (ER, PR), human epidermal growth factor recep- tor 2 (HER2) and proliferation index (Ki67) in breast cancer.
Chicago-viite (17. p.)Heikinmäki, Nella, Matemaattis-luonnontieteellinen tiedekunta, Faculty of Sciences, Bio- ja ympäristötieteiden laitos, Department of Biological and Environmental Science, Jyväskylän yliopisto, ja University of Jyväskylä. Validation of the Breast Cancer Analysis Protocol Packages (APPs) for the Determination of Estrogen and Progesterone Receptors (ER, PR), Human Epidermal Growth Factor Recep- Tor 2 (HER2) and Proliferation Index (Ki67) in Breast Cancer. 2022.
MLA-viite (9. p.)Heikinmäki, Nella, et al. Validation of the Breast Cancer Analysis Protocol Packages (APPs) for the Determination of Estrogen and Progesterone Receptors (ER, PR), Human Epidermal Growth Factor Recep- Tor 2 (HER2) and Proliferation Index (Ki67) in Breast Cancer. 2022.